Bioshares Biotechnology Clinical (NYSEARCA:BBC) Short Interest Decreased By 13.27%

December 8, 2017 - By Peter Erickson

 Bioshares Biotechnology Clinical (NYSEARCA:BBC) Short Interest Decreased By 13.27%

The stock of Bioshares Biotechnology Clinical (NYSEARCA:BBC) registered a decrease of 13.27% in short interest. BBC’s total short interest was 121,600 shares in December as published by FINRA. Its down 13.27% from 140,200 shares, reported previously. With 21,900 shares average volume, it will take short sellers 6 days to cover their BBC’s short positions.

The ETF increased 4.13% or $1.108 during the last trading session, reaching $27.948. About 6,746 shares traded. Virtus LifeSci Biotech Clinical Trls ETF (NYSEARCA:BBC) has risen 20.72% since December 8, 2016 and is uptrending. It has outperformed by 4.02% the S&P500.

More important recent Virtus LifeSci Biotech Clinical Trls ETF (NYSEARCA:BBC) news were published by: Globenewswire.com which released: “BioShares Biotechnology ETFs Complete Semi-Annual Rebalance and Recomposition” on June 16, 2017, also Benzinga.com published article titled: “Life (Science) Lessons: The Hows And Whos To Play Biotech”, Marketwatch.com published: “Virtus LifeSci Biotech Clinical Trials ETF” on December 16, 2014. More interesting news about Virtus LifeSci Biotech Clinical Trls ETF (NYSEARCA:BBC) was released by: Nasdaq.com and their article: “Best Sector ETF of Q3 and its Top-Performing Stocks” with publication date: October 02, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: